--- a
+++ b/clusters/9knumclustersv2/clust_1312.txt
@@ -0,0 +1,56 @@
+Negative human immunodeficiency virus (HIV) test at screening.
+Negative serology for human immunodeficiency virus (HIV)
+Negative human immunodeficiency virus (HIV) antibody.
+Obtained within  days prior to CD: Rapid human immunodeficiency virus (HIV) / antibodies negative
+Have negative test result for human immunodeficiency virus (HIV) and hepatitis B or C testing
+Hepatitis B and C negative (unless the result is consistent with prior vaccination or prior infection with full recovery); human immunodeficiency virus (HIV) negative
+DONOR: Donor is human immunodeficiency virus (HIV) negative
+Negative human immunodeficiency virus (HIV) antibody.
+Negative human immunodeficiency virus (HIV) test ---Negative hepatitis B surface antigen (HBsAg) test at screening
+Documented negative serologic testing for human immunodeficiency virus (HIV)
+Negative human immunodeficiency virus (HIV), hepatitis B and C, and tuberculosis (TB) test
+DONOR: Human immunodeficiency virus (HIV) negative
+Negative serology for human immunodeficiency virus (HIV)
+Known human immunodeficiency virus (HIV) disease (requires negative test for clinically suspected HIV infection)
+Human immunodeficiency virus (HIV)-negative
+Patients must be negative for human immunodeficiency virus (HIV)
+DONOR: Human immunodeficiency virus (HIV) negative
+Negative serology for human immunodeficiency virus (HIV)
+Human immunodeficiency virus (HIV) negative
+Patients must be human immunodeficiency virus (HIV) negative, and have negative serologies for hepatitis C
+Human immunodeficiency virus (HIV) negative
+Human immunodeficiency virus (HIV) negative
+Human immunodeficiency virus (HIV) negative
+Human immunodeficiency virus (HIV): negative HIV antibody / polymerase chain reaction (PCR)
+Participants must have a negative human immunodeficiency virus (HIV) antibody/antigen test and negative Chlamydia (C.) trachomatis/Neisseria (N.) gonorrhea nucleic acid amplification test (NAAT)
+Negative human immunodeficiency virus (HIV)-/ serology
+Human immunodeficiency virus (HIV) negative
+Human immunodeficiency virus (HIV) and hepatitis c negative (serology)
+Participants must be human immunodeficiency virus (HIV) negative =<  months prior to screening
+Patient must have documentation of negative human immunodeficiency virus (HIV)- testing within  weeks prior to study registration (separate counseling and consent as per institutional guidelines)
+HIV negative
+Human immunodeficiency virus (HIV) negative
+Negative human immunodeficiency virus (HIV) screening test
+Negative human immunodeficiency virus (HIV) antibody
+Negative human immunodeficiency virus (HIV) serology
+Patients must be test negative for human immunodeficiency virus (HIV), hepatitis B and C
+DONOR: Human immunodeficiency virus (HIV) negative
+Patients must have negative human immunodeficiency virus (HIV) serology
+Human immunodeficiency virus (HIV) test must be negative
+Donor human immunodeficiency virus (HIV) negative
+Human immunodeficiency virus (HIV) antibody negative
+Human immunodeficiency virus (HIV) = negative
+Negative human immunodeficiency virus (HIV) antibody
+HIV negative.
+Human immunodeficiency virus (HIV) negative (can be pending at this time)
+Negative for human immunodeficiency virus (HIV)
+Human Immunodeficiency Virus (HIV) negative* * Status of HIV must be confirmed via a HIV antibody test or other confirmatory tests available within  months before screening or at screening
+DONOR: Human immunodeficiency virus (HIV) negative
+DONOR: Human immunodeficiency virus (HIV) negative
+Human immunodeficiency virus (HIV) negative
+Human immunodeficiency virus (HIV) negative
+DONOR: Human immunodeficiency virus (HIV) negative
+Patients must be human immunodeficiency virus (HIV) negative
+Human immunodeficiency virus (HIV) negative
+Human immunodeficiency virus (HIV) negative by standard blood testing
+Donor human immunodeficiency virus (HIV) negative (if autologous product  patient must be HIV negative)